4//SEC Filing
Connaughton Bernadette 4
Accession 0001415889-25-011767
CIK 0001159036other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:02 PM ET
Size
7.6 KB
Accession
0001415889-25-011767
Insider Transaction Report
Form 4
Connaughton Bernadette
Director
Transactions
- Award
Common Stock
2025-05-01+4,165→ 50,952 total - Award
Option to Purchase Common Stock
2025-05-01+5,750→ 5,750 totalExercise: $60.03Exp: 2035-05-01→ Common Stock (5,750 underlying)
Footnotes (2)
- [F1]Represents annual restricted stock unit ("RSU") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 1, 2026 and (ii) the date of the Issuer's next annual meeting of stockholders.
- [F2]Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 1, 2026 and (ii) the date of the Issuer's next annual meeting of stockholders.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001662521
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:02 PM ET
- Size
- 7.6 KB